In April 2010, Ecuador issued a compulsory license for lopinavir/ritonavir, an AIDS medication. ❋ Robert Naiman (2010)
Two were anti-AIDS drugs (efavirenz and lopinavir/ritonavir) and the third is used to treat patients with cardio-vascular disease (clopidogrel). ❋ Unknown (2008)
A cocktail of second-line treatments for adults -- combining tenofovir, lamivudine and lopinavir/ritonavir -- has been discounted to about $659 a year, down from prevalent market prices ranging from $1,000 to more than $4,000 a year in low - and middle-income countries, respectively, said Anil Soni, the Clinton foundation's chief operating officer. ❋ Unknown (2008)
Both lopinavir and ritonavir, the two antiretroviral agents in Kaletra, were researched with public money. ❋ Unknown (2007)
They found that serum taken from people who were taking antiretroviral therapy - which included ritonavir-boosted saquinavir (Invirase) or lopinavir (Kaletra) - showed significant antimalarial activity. ❋ Unknown (2006)
India on its drug Kaletra - a combination of the two antiretroviral medicines lopinavir and ritonavir. ❋ Sarah Boseley (2011)
The ritonavir-boosted protease inhibitors studied were lopinavir, atazanavir, darunavir and fosamprenavir; the NNRTI was efavirenz and the NRTI was tenofovir.
In Study 045, REYATAZ/ritonavir and lopinavir/ritonavir were similar for the primary efficacy measure of time-averaged difference in change from baseline in HIV RNA.
This study was not large enough to reach a definitive conclusion that REYATAZ/ritonavir and lopinavir/ritonavir are equivalent on the secondary efficacy measure of proportions below the HIV RNA lower limit of detection.
Do not take Kaletra if you are allergic to any of its ingredients, including lopinavir or ritonavir. ❋ Unknown (2010)
Kaletra should not be taken by people who are allergic to Kaletra or any of its ingredients, including lopinavir or ritonavir. ❋ Unknown (2010)
All told, McIntyre said, 42 of the women getting nevirapine (or 17%) and 50 getting lopinavir (or 20%) either died or had a virologic failure, a difference that was not statistically significant. ❋ Unknown (2010)
Adverse effects were roughly similar between the arms, McIntyre said, but 35 women in the nevirapine arm stopped treatment because of an adverse event compared with none in the lopinavir arm, a difference that was significant at ❋ Unknown (2010)
At 48 weeks, he said, 85. 7% of those getting nevirapine and 86. 3% of those getting lopinavir were alive and without virologic failure. ❋ Unknown (2010)
This is the same technology used to develop Abbott's Kaletra® (lopinavir/ritonavir) tablet, which combines lopinavir and ritonavir. ❋ Unknown (2010)
Kaletra® (lopinavir/ritonavir) is a prescription anti-HIV-1 medicine called a protease inhibitor that contains lopinavir and ritonavir. ❋ Unknown (2010)
